FUNCTIONAL STATES OF THE RYANODINE RECEPTOR (RYR) & 3D STRUCTURE OF TRIAD
兰尼碱受体 (RYR) 的功能状态
基本信息
- 批准号:8172269
- 负责人:
- 金额:$ 0.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-07 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAgonistAmino AcidsAntibodiesBindingBinding SitesBrainCalciumCalmodulinCalsequestrinCarbonCardiacCategoriesCell membraneCholinergic ReceptorsClinicalCollaborationsCommunicationComplexComputer Retrieval of Information on Scientific Projects DatabaseCouplingCryoelectron MicroscopyCyclic AMP-Dependent Protein KinasesCytoplasmDetergentsDevelopmentDihydropyridine ReceptorsDilution TechniquesDiseaseDissociationDistantEnvironmentEquilibriumEventExhibitsExposure toFreezingFunctional disorderFundingGated Ion ChannelGoalsGrantGreen Fluorescent ProteinsHeartHeart DiseasesHot SpotImageImageryIn VitroIncubatedIndividualInstitutionIon ChannelIonsKineticsL-Type Calcium ChannelsLaboratoriesLeadLifeLigand BindingLigandsLipid BilayersLocationManuscriptsMapsMediatingMembraneMembrane ProteinsMethodologyMethodsMicroscopyMolecular BiologyMolecular ConformationMonitorMontserratMuscleMuscle ContractionMutateMutationMyocardiumMyopathyNatureNeuronsNucleotidesPaperPhosphorylation SitePhysiologicalPlayPreparationProcessPropertyProtein IsoformsProteinsPublishingReactionReaction TimeReportingResearchResearch PersonnelResolutionResourcesRoleRyR1RyR2Ryanodine Receptor Calcium Release ChannelRyanodine ReceptorsSarcolemmaSarcoplasmic ReticulumScientistSemliki forest virusSerineSerine Phosphorylation SiteSignal TransductionSiteSkeletal MuscleSocietiesSolubilitySolutionsSourceStimulusStructureSubcellular structureSurfaceTacrolimus Binding ProteinsTechniquesTechnologyTerminal DiseaseTestingTimeTomogramTransmembrane DomainTriad Acrylic ResinUnited States National Institutes of HealthVesicleWorkabstractingdensitydisease-causing mutationelectron tomographyexperienceflash photolysisimage processingimage reconstructionimprovedin vivoinhibitor/antagonistinterestligand gated channelmacromoleculemedical schoolsmolecular massparticlepreventprogramsreceptorreceptor structure functionreconstitutionreconstructionresearch studyresponsesensorskeletalsuccesssudden cardiac deaththree dimensional structuretime intervaltime usetomographyvoltage
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
ABSTRACT:
RyRs function as intracellular calcium release channels that are particularly prevalent in muscle where they are associated with the sarcoplasmic reticulum (SR). RyRs are homotetramers constructed from a subunit of molecular mass 565 Kda, making these receptors the largest known ion channels (Samso and Wagenknecht, 1998; Fill and Copello, 2002; Wagenknecht and Samso, 2002). The Wagenknecht laboratory has been engaged in structural studies of isolated RyRs from skeletal and heart muscle by cryoelectron microscopy and three-dimensional reconstruction for the past 12 years (Liu et al., 2004; Radermacher et al., 1992). 3D reconstructions have shown that about 80% of the mass of the RyR is located in the cytoplasm as a complex assembly of ~10 distinct domains (Radermacher et al., 1994). Besides their function in releasing calcium, which is the immediate stimulus for muscle contraction, RyRs play a key role in excitation-contraction (E-C) coupling. E-C coupling refers to the process by which neuron-induced depolarization of the muscle plasma membrane (sarcolemma) and it invaginations known as transverse (t)-tubules) leads to release of Ca2+ from the SR via the RyRs. Perhaps the most important of the sarcolemma/t-tubule components is an L-type calcium channel known as the dihydropyridine receptor, which serves as the voltage sensor in e-c coupling (Rios and Pizarro, 1991;Jones, 2002). Interactions between the dihydropyridine receptor and the cytoplasmic region of the RyR are thought to mediate communication between the plasma membranes/transverse tubules and the transmembrane, ion-conducting region of the RyR in the SR.
The RyR is a ligand-gated channel. Physiologic ligand activators of the skeletal RyR include the dihydropyridine receptor (the voltage-sensor), Ca2+ at micromolar levels, and millimolar ATP. Inhibitors include Ca2+ and Mg2+ at millimolar concentrations. In a pioneering study that employed time-resolved cryo-microscopy, Unwin demonstrated that the acetylcholine receptor, also a ligand-gated ion channel, could be imaged in two of its functional states, a closed and an open state (Unwin, 1995). Time-resolved techniques were required because when the acetylcholine receptor is induced to open by physiologic agonists (in this case acetylcholine), the open state is short-lived, lasting only 50-100 ms before assuming a desensitized (inactivated) state.
Until recently it was not clear whether isolated RyRs inactivated, but now several studies have uncovered rather slow transitions (time constants ~100 ms to seconds, depending on experimental conditions) from the open form to states that have been described as either "inactivated"or "adapted" (Schiefer et al., 1995; Laver and Lamb, 1998;Valdivia et al., 1995) Gyorke and Fill, 1993) ; Lamb et al., 2000; Fill et al., 2000). Controversy currently exists regarding the precise nature and physiologic significance of these newly identified states of the RyR, and also regarding the disparate results that have been obtained in different laboratories. Evidence is mounting for a physiological role for inactivation of the heart isoform of the RyR to prevent uncontrolled calcium-induced calcium release (Wang et al., 2004).
The mechanism of excitation-contraction (e-c) coupling is a major research problem among muscle physiologists. Ryanodine receptors play a key role in the signal-transducing events of the process. Our research will provide structural details of the e-c coupling apparatus using what are perhaps the only methods available for obtaining this information. Several muscle diseases are known to involve mutations of the ryanodine receptor, and there is evidence that RyRs play roles in heart disease and brain function as well.
Our entire research program on RyRs depends on single-particle image processing methodology (TRD#3) and cryo-EM technology (TRD#2), as described in detail above. Electron tomography of frozen-hydrated subcellular structures (TRD#1) is also essential to one component of our program (Project 3 above).
Project 1: Three-dimensional reconstruction of closed, open and inactivated/adapted states of skeletal and cardiac RyR
Closed states of the RyR are easy to achieve by simply withholding activators. Open states will be induced by rapid addition of activators followed by freezing for cryo-EM at defined time intervals of sufficiently short duration that inactivated/adapted states will not form. The technology developed in TRD#2 is necessary to carry out the proposed experiments. There is good reason to anticipate that interesting structural changes will be observable between the closed and open states. Our own group and a group at Baylor have published cryo-EM studies of RyRs in putatively open (but possibly inactivated) states that were obtained treating the receptor with appropriate levels of Ca2+ and nucleotide Sharma et al., 2000; Serysheva et al., 1999). Signficant structural differences were detected between the two states, not only in the transmembrane regions as might be expected, but, surprisingly, also in the cytoplasmic regions at distances quite distant (>100 ¿) from the ion channel. To confirm and improve upon these findings, the RyR should be studied in the open form at several time points following addition of activators. We plan to activate RyRs by exposing them to the activator, Ca2+, by flash photolysis of caged Ca2+ (Ca2+-Dinitrophen) as has been done for electrophysiologyl experiments on RyRs (Gyorke et al., 1994). Alternatively, the microdroplet spray approach could also be used to expose RyRs on the grid to activators contained in the spray. The pre-mix approach may be preferable if we find that reaction times greater than 1 second are sufficiently short to trap the open state of RyR.
The time-resolved approach may prove to be indispensable for reasons other than preventing formation of undesirable, slow-forming conformational states of the RyR. All of the cryo-EM studies on the RyR to date have been conducted on purified, detergent-solubilized material. The presence of detergent and the lack of a membrane bilayer in these preparations could lead to conclusions that are not valid for the receptor in its natural environment.
We have found that at reduced levels of detergents, the closed form of the receptor remains soluble for short periods (minutes) of time (Wagenknecht et al., 1997; Wagenknecht et al., 1994). However, our initial experiments to characterize the open form of the RyR at low concentrations of detergent often showed unacceptably high amounts of apparently aggregated receptors on the EM grid. By performing these same experiments using time-resolved methods we will be able time to reduce the time of exposure to low detergent levels to less than 1 second; this should greatly reduce solubility problems, and allow even lower levels of detergent to be used. The advantages of rapid-dilution to remove detergents could be substantial and of general applicability to membrane proteins or, more generally to any macromolecule that becomes prone to aggregation upon a change in solution conditions or addition of a ligand (e.g. as was indeed found for a low pH-induced conformational state of Semliki Forest virus (Fuller et al., 1995). Eventually, we expect to be able to study the RyRs in a lipid bilayer environment where functional activities can be monitored in parallel with structural work. Some preliminary success has already been achieved in imaging RyRs reconstituted into bilayers (Liu and Wagenknecht, 1999). More generally, for macromolecular machines that are metastable, such as RyR, precautions to reduce exposure to the carbon surface of the EM grid might be beneficial to retention of native structure even in non-time-resolved experiments (Trujillo et al., 2004)
As discussed above, evidence is accumulating that RyRs can exist in at least three major conformations: closed, open, and inactivated (and/or adapted). Probably there are multiple states within each of these major categories (Laver and Lamb, 1998). As our understanding of the transitions between the various states improves, it should become feasible to characterize the structure of the inactivated (or adapted) state by cryo-EM and image reconstruction. It may even prove feasible to follow the kinetics of structural transitions undergone by the receptor in response to conditions that mimic those experienced by the receptor in vivo.
In the previous reporting period, we have continued our collaboration with Dr. S.R.W. Chen (Calgary) to map functionally significant amino-acid residues on RyR's 3D structure by insertion of the green fluorescent protein at the sites of interest followed by cryo-EM and single-particle image processing of the purified mutated receptors. Two sites that are within or adjacent to regions of RyR2 that are mutated in certain sudden cardiac death diseases have been mapped in the past year by Dr. Zheng Liu who is the Wadsworth scientist leading this effort. One of these mapping results has been published. Studies of a third site in the disease regions are underway. We are testing an intriguing hypothesis due to Ikemoto, 2005 (Chapter 6 in Ryanodine Receptors: Structure, Function and Dysfunction in Clinical Disease, X.H.T. Wehrens and A.R. Marks, eds., Springer) in which disease-causing mutations are proposed to cause destabilization of an interaction between two key structural domains within RyR2. Time-resolved cryo-microscopy experiments are planned to test this hypothesis.
+ Liu, Z., Wang, R., Zhang, J., Chen, S.R.W., and Wagenknecht, T. (2005) Localization of a disease-associated mutation hotspot on the three-dimensional structure of cardiac ryanodine receptor. J. Biol. Chem. 280: 37941-37947. PMCID 1470666.
Project 2: 3D structure of complexes of RyR and protein ligands
RyRs are known to interact directly in with several proteins in skeletal muscle to form a signal-transducing complex known as the triad junction. One goal is to use the isolated RyR as an "assembly platform" to prepare complexes containing each of these ligands. Already, we have made progress in determining the binding locations of two ligands, FK506-binding protein and calmodulin, on the surface of the RyR (Wagenknecht et al., 1994; Wagenknecht et al., 1996; Wagenknecht et al., 1997; Samso and Wagenknecht, 2002; Sharma et al. 2004 (submitted)). Of particular interest is the interaction of the RyR with the dihydropyridine receptor (Samso et al., 1999), which is thought to represent the core of the signal-tranducing apparatus of e-c coupling. Sequence-specific antibodies represent another class of ligand that is being used to probe the structure of the RyR by means of in vitro assembly and 3D cryo-microscopy.
RyRs also exhibit the somewhat unusual property of binding the regulator molecule, calmodulin, in both its apo and Ca2+-bound forms (Meissner, 2002; Tang et al., 2002). Thus, calmodulin could be considered to be a resident regulatory component of the RyR; a similar role for calmodulin has been postulated for other ion channels (Budde et al., 2002). Interestingly, our structural analyses by single-particle cryo-EM have shown two discrete binding sites, separated by about 30 ¿ngstroms, for the two forms of calmodulin (Samso and Wagenknecht, 2002; Wagenknecht et al., 1997). We have hypothesized that calmodulin swithches between these two sites without dissociating from the ryanodine receptor. We propose to test this hypothesis using time-resolved cryo-EM to induce the putative switch of binding sites in the absence of exogenous calmodulin.
Since the equilibrium constants for ligands vary widely, it is frequently desirable to perform the assembly reactions using RyR and ligand at concentrations that are higher than optimal for EM (~10-7 M for RyR) so as to maximize the fraction of RyR that has bound ligand. The development of rapid dilution techniques of time-resolved cryo-microscopy (TRD2) will allow RyR ligands with lower affintities (Kd>10-7) ¿ to be incubated at concentrations appropriate for obtaining high yields (>90%), and then to be rapidly diluted for cryo-EM within a time frame that is much slower than the rate of ligand dissociation. The use of the rapid dilution technique for obtaining high yields of in vitro assembly products for cryo-microscopy may well prove to be its most powerful application.
Dr. Montserrat Samso (Harvard Medical School) continued to collaborate with Dr. Wagenknecht on high resolution studies of RyR structure since she departed the Wadsworth Center. Using Resource cryo-EM facilities she has determined the highest resolution structure yet attained for the ryanodine receptor, 12-14¿. A manuscript on this work has been published:
+ Sams¿, M., Wagenknecht, T.W., and Allen, P.D. (2005) Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-electron microscopy. Nature Structural and Molecular Biology 12:539-544. PMCID 1925259.
+ Jones, P., Meng, X., Cai, S., Bolstad, J., Wagenknecht, T., Liu, Z., and Chen, S.R. (2008) Localization of PKA phosphorylation site, Ser 2030, in the three-dimensional structure of cardiac cyanodine receptor. Biochem. Society 410, 261-270.
The following three papers related to this subproject were published:
+ Jones,P.P., Meng, X., Xiao, B., Cai, S., Bolstad, J., Wagenknecht, T., Liu, Z., and Chen, S.R.W. (2007). Localization of PKA phosphorylation site, serine-2030, in the three-dimensional structure of cardiac ryanodine receptor. Biochem J (in press).
+ Meng, X., Xiao, B.L., Cai, S.T., Huang, X.J., .Li, F., Bolstad, J., Trujillo, R., Airey, J., Chen, S.R.W., Wagenknecht, T., and Liu, Z. (2007) Three-dimensional localization of serine 2808, a phosphorylation site in cardiac ryanodine receptor. J. Biol. Chem. 282:25929-25939.
+ Wang, R., Chen, W., Cai, S., Zhang, J., Bolstad, J., Wagenknecht, T., Liu, Z., and Chen, S.R. (2007) Localization of an NH(2)-terminal disease-causing mutation hot spot to the "clamp" region in the three-dimensional structure of the cardiac ryanodine receptor. J. Biol. Chem. 282:17785-17793.
Project 3: Cryo-tomography of the skeletal muscle triad junction.
Work in other laboratories has shown that it is feasible to isolate membrane fractions from skeletal muscles that contain functionally intact triads (Ikemoto et al., 1994). Low resolution microscopy on these preparations shows the presence of intact triads (i.e. sarcoplasmic reticulum-derived vesicles joined to transverse-tubule-derived vesicles with RyRs visible in the intermembrane space in the junctional regions) (Kim et al., 1990), and cryo-EM of frozen-hydrated triads yields images in which the bridging RyRs are directly visible. During the current grant period we determined the first tomograms from frozen-hydrated isolated triad junctions (Wagenknecht et al., 2002) The reconstruction resolved some of the individual ryanodine receptors and revealed their relationship to the dense mat of luminal density attributed to calsequestrin that underlies the RyR-enriched regions of the SR. Frozen-hydrated triads should be a readily amenable to the application of high-precision immuno-EM to identify protein components that are resolved in the tomograms. A potentially interesting application of time-resolved tomography would be to look for changes in density attributed to calsequestrin as calcium reserves are depleted via release of Ca2+ through the RyRs.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERENCE C WAGENKNECHT其他文献
TERENCE C WAGENKNECHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERENCE C WAGENKNECHT', 18)}}的其他基金
NEW TECHNOLOGIES FOR TIME-RESOLVED INVESTIGATIONS
用于时间分辨调查的新技术
- 批准号:
8172286 - 财政年份:2010
- 资助金额:
$ 0.54万 - 项目类别:
CONTINUING DEVELOPMENT OF MIXER SPRAYER AND FLASH
混合喷雾器和闪蒸器的持续开发
- 批准号:
8172272 - 财政年份:2010
- 资助金额:
$ 0.54万 - 项目类别:
CONTINUING DEVELOPMENT OF MIXER SPRAYER AND FLASH
混合喷雾器和闪蒸器的持续开发
- 批准号:
7954574 - 财政年份:2009
- 资助金额:
$ 0.54万 - 项目类别:
FUNCTIONAL STATES OF THE RYANODINE RECEPTOR (RYR) & 3D STRUCTURE OF TRIAD
兰尼碱受体 (RYR) 的功能状态
- 批准号:
7954568 - 财政年份:2009
- 资助金额:
$ 0.54万 - 项目类别:
NEW TECHNOLOGIES FOR TIME-RESOLVED INVESTIGATIONS
用于时间分辨调查的新技术
- 批准号:
7954591 - 财政年份:2009
- 资助金额:
$ 0.54万 - 项目类别:
FUNCTIONAL STATES OF THE RYANODINE RECEPTOR (RYR) & 3D STRUCTURE OF TRIAD
兰尼碱受体 (RYR) 的功能状态
- 批准号:
7598340 - 财政年份:2007
- 资助金额:
$ 0.54万 - 项目类别:
FUNCTIONAL STATES OF THE RYANODINE RECEPTOR (RYR) & 3D STRUCTURE OF TRIAD
兰尼碱受体 (RYR) 的功能状态
- 批准号:
7357268 - 财政年份:2006
- 资助金额:
$ 0.54万 - 项目类别:
DEVELOPMENT OF TIME-RESOLVED 3 D CRYOELECTRON MICROSCOPY
时间分辨 3D 冷冻电子显微镜的发展
- 批准号:
6976406 - 财政年份:2004
- 资助金额:
$ 0.54万 - 项目类别:
CRYO TOMOGRAPHY OF SKELETAL MUSCLE TRIAD JUNCTION
骨骼肌三联结的冷冻断层扫描
- 批准号:
6976403 - 财政年份:2004
- 资助金额:
$ 0.54万 - 项目类别:
相似国自然基金
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于纳米铝乳剂和模式识别受体激动剂的复合型佐剂研究
- 批准号:82341043
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡瓦胡椒中选择性大麻素2型受体激动剂的发现及其抗骨质疏松作用研究
- 批准号:82360684
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
烟碱乙酰胆碱受体门控和毒素抑制的结构基础
- 批准号:
10322038 - 财政年份:2022
- 资助金额:
$ 0.54万 - 项目类别:
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
烟碱乙酰胆碱受体门控和毒素抑制的结构基础
- 批准号:
10848770 - 财政年份:2022
- 资助金额:
$ 0.54万 - 项目类别:
Small molecule mimetics of Humanin that normalize neuronal p-Akt as novel therapeutics for AD
护脑素小分子模拟物可使神经元 p-Akt 正常化,作为 AD 的新型疗法
- 批准号:
10211023 - 财政年份:2021
- 资助金额:
$ 0.54万 - 项目类别:
Desensitization of Nicotinic Acetylcholine Receptors
烟碱乙酰胆碱受体的脱敏
- 批准号:
9920740 - 财政年份:2017
- 资助金额:
$ 0.54万 - 项目类别:
Desensitization of Nicotinic Acetylcholine Receptors
烟碱乙酰胆碱受体的脱敏
- 批准号:
9378463 - 财政年份:2017
- 资助金额:
$ 0.54万 - 项目类别: